Side Effects of Newer Antipsychotics in Older Adults

PHASE4CompletedINTERVENTIONAL
Enrollment

406

Participants

Timeline

Start Date

August 31, 2005

Primary Completion Date

October 31, 2010

Study Completion Date

October 31, 2010

Conditions
SchizophreniaAlzheimer's DiseaseDementia
Interventions
DRUG

Aripiprazole

Participant will take aripiprazole. Dosing will be determined by each participant's psychiatrist.

DRUG

Olanzapine

Participant will take olanzapine. Dosing will be determined by each participant's psychiatrist.

DRUG

Risperidone

Participant will take risperidone. Dosing will be determined by each participant's psychiatrist.

Trial Locations (1)

92037

University of California, San Diego, San Diego

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Veterans Medical Research Foundation

OTHER

NCT00245206 - Side Effects of Newer Antipsychotics in Older Adults | Biotech Hunter | Biotech Hunter